» Articles » PMID: 20564651

Epidemiology of Pediatric Inflammatory Bowel Disease: a Systematic Review of International Trends

Overview
Specialty Gastroenterology
Date 2010 Jun 22
PMID 20564651
Citations 327
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Temporal trends in the incidence of pediatric-onset inflammatory bowel disease (IBD) are controversial and a wide range of estimates have been reported worldwide. We conducted a systematic review of research describing the epidemiology of childhood-onset IBD to assess changes in incidence rates over time and to evaluate international differences.

Methods: The following electronic databases were searched for articles published 1950-2009: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and Cochrane IBD/Functional Bowel Disorders Group Specialised Trial Register. All included studies reported incidence or prevalence of IBD, Crohn's disease (CD) or ulcerative colitis (UC). Two authors independently completed the data extraction form for each eligible study. Choropleth maps demonstrated the international incidence of IBD, CD, and UC. Incidence of CD and UC was graphed using data from studies reporting rates in multiple time periods.

Results: The search yielded 2209 references and review resulted in 139 included studies from 32 countries. A wide range of incidence was reported internationally; however, rates of IBD were not described in most countries. Twenty-eight studies (20.1%) used statistical analysis to assess trends over time, and 77.8% reported statistically significantly increased incidence of pediatric IBD. Of studies calculating statistical trends in CD incidence, 60% reported significantly increased incidence. Of similar UC studies, 20% reported significantly increased incidence.

Conclusions: Globally rising rates of pediatric IBD (due primarily to the rising incidence of CD) was demonstrated in both developed and developing nations; however, most countries lack accurate estimates. Analyzing incidence trends may help identify specific environmental and genetic risk factors for pediatric IBD.

Citing Articles

Biologics in the management of pediatric inflammatory bowel disease: When and what to choose.

Samanta A, Srivastava A World J Clin Pediatr. 2025; 14(1):100938.

PMID: 40059900 PMC: 11686582. DOI: 10.5409/wjcp.v14.i1.100938.


Functional characterization of novel anti-DEFA5 monoclonal antibody clones 1A8 and 4F5 in inflammatory bowel disease colitis tissues.

Thangaiyan R, Sakwe A, Hawkins A, Washington M, Ballard B, Izban M Inflamm Res. 2025; 74(1):30.

PMID: 39883179 PMC: 11782311. DOI: 10.1007/s00011-024-01970-w.


Microscopic messengers: microbiota-derived bacterial extracellular vesicles in inflammatory bowel disease.

Zubair M, Abouelnazar F, Dawood A, Pan J, Zheng X, Chen T Front Microbiol. 2024; 15:1481496.

PMID: 39606115 PMC: 11600980. DOI: 10.3389/fmicb.2024.1481496.


Establishment and Characterization of Patient-Derived Intestinal Organoids from Pediatric Crohn's Disease Patients.

An S, Huh H, Ko J, Moon J, Cho K Pediatr Gastroenterol Hepatol Nutr. 2024; 27(6):355-363.

PMID: 39563842 PMC: 11570352. DOI: 10.5223/pghn.2024.27.6.355.


Outcome of pediatric inflammatory bowel disease in Asian children: a multinational 1-year follow-up study.

Tanpowpong P, Treepongkaruna S, Huang J, Huang J, Chew K, Mercado K Clin Exp Pediatr. 2024; 68(3):247-256.

PMID: 39533716 PMC: 11884952. DOI: 10.3345/cep.2024.01144.